C. Daniel Myers

Insider Reports History

Location
Alpharetta, GA
Signature
/s/ Mary Reumuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by C. Daniel Myers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KALA BIO, Inc. Director Common Stock 10.4K $41.9K $4.04 Jun 15, 2025 Direct
ALIMERA SCIENCES INC Chairman Emeritus Stock Option (Right to Buy) 6K Aug 1, 2023 Direct
KALA BIO, Inc. Director Stock Option (right to buy) 5.45K Jun 15, 2025 Direct

Insider Reports Filed by C. Daniel Myers

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALA KALA BIO, Inc. Jun 15, 2025 2 $0 4 Jun 17, 2025 Director
KALA KALA BIO, Inc. Jun 11, 2024 2 $0 4 Jun 12, 2024 Director
ALIM ALIMERA SCIENCES INC Aug 1, 2023 1 $0 4 Aug 3, 2023 Chairman Emeritus
KALA Kala Pharmaceuticals, Inc. Jun 22, 2023 4 $0 4 Jun 23, 2023 Director
KALA Kala Pharmaceuticals, Inc. May 31, 2023 3 $0 4 Jun 2, 2023 Director
ALIM ALIMERA SCIENCES INC Jan 4, 2023 1 $0 4 Jan 6, 2023 Director
KALA Kala Pharmaceuticals, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
ALIM ALIMERA SCIENCES INC Nov 2, 2021 1 $0 4 Nov 4, 2021 Director
KALA Kala Pharmaceuticals, Inc. Oct 15, 2021 1 $0 4 Oct 19, 2021 Director
KALA Kala Pharmaceuticals, Inc. Oct 15, 2021 0 $0 3 Oct 19, 2021 Director